期刊文献+

静脉注射免疫球蛋白对神经病理性疼痛治疗作用的研究进展 被引量:10

Research progress of therapy of intravenous immunoglobulin on neuropathic pain
下载PDF
导出
摘要 静脉注射免疫球蛋白具有多种免疫调节方面的功能,临床上常用于自身免疫性疾病的治疗。近年来,静脉注射免疫球蛋白也应用于许多神经系统疾病的治疗,因为部分神经系统疾病的发病机制与免疫调节相关。神经病理性疼痛是慢性顽固性的疼痛综合征,发病机制复杂,免疫调节也参与神经病理性疼痛的发生。目前发现静脉注射免疫球蛋白可以明显减轻神经病理性疼痛患者的疼痛,给药后无严重不良反应的发生,而且在镇痛的同时可以促进伤口的愈合,提高患者的生活质量。其作用机制可能是免疫球蛋白可以阻断自身抗体与Fc受体结合或中和自身抗体,减轻补体介导的组织损伤作用;还可以通过降低炎性细胞因子表达减轻患者的疼痛。 Intravenous use of immunoglobulin exhibits many immuno-modulatory properties and has been used clinically to treat several autoimmune disease.Currently,immunoglobulin is being investigated as an immuno-modulatory therapy in many neurological diseases.Neuropathic pain is choronic intractable pain syndrome,which has complex mechanisms,immuno-modulatory involved.Recently,intravenous immunoglobulin has significant antinocicetptive effect on neuropahtic pain patients,without any serious adverse reactions.It improves functional recovery,and quality of life.The mechanism may be blocking immunoglobulin binding with Fc receptor or neutralizing antibodies to reduce the damage of complement-mediated;may also reduce inflammatory cytokines in patients with neurological disease.
出处 《中国临床药理学与治疗学》 CAS CSCD 2015年第2期213-216,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 山东省自然科学基金(ZR2012HL27) 潍坊医学院科技创新研究基金(K11QC1001) 国家自然科学基金(81300969) 潍坊市科技局课题(20121373)
关键词 镇痛 免疫球蛋白 免疫调节 神经病理性疼痛 analgesic immunoglobulin immuno-modulatory neuropathic pain
  • 相关文献

参考文献21

  • 1李招胜,林洪,沙漠,丁真奇.神经病理性疼痛的药物治疗研究进展[J].中国临床药理学与治疗学,2013,18(9):1076-1080. 被引量:23
  • 2Ellis A, Bennett DL. Neuroinflammation and the generation of neuropathic pain[J]. Br J Anaesth, 2013,111(1) :26-37.
  • 3Napoli I, Noon LA, Ribeiro S, et al. A central role for the ERK signaling pathway in controlling Schwann cell plasticity and peripheral nerve regen- eration in vivo[J]. Neuron, 2012, 73(4): 729-742.
  • 4Nicotra L, Loram LC, Watkins LR, et al. Toll-like receptors in chronic pain[J]. Exp Neurol,2012, 234 (2) : 316-329.
  • 5Colton CA. Microglial-neuronal interactions during neurodegenerative diseases [J]. J Neuroimmune Pharmacol, 2013, 8(1):4-6.
  • 6Olson JK. Immune response by microglia in the spi- nal cord[J]. Ann N Y Acad Sci, 2010, 1198:271- 278.
  • 7Liao YH, Zhang GH, Jia D, et al. Spinal astrocyticactivation contributes to mechanical allodynia in a mouse model of type 2 diabetes [J]. Brain Res, 2011, 1368: 324-335.
  • 8Goebel A. Immunoglobulin responsive chronic pain [J]. J Clin Imuunol,2010,30(Suppl 1) :S103-108.
  • 9Kawagashira Y, Watanabe H, Morozumi S, et al. Differential response to intravenous immunoglobulin (IVIg) therapy among multifocal and polyneuropa- thy types of painful diabetic neuropathy[J]. J Clin Neurosci,2010 (17) : 1003-1008.
  • 10杨琴,杨军,李光勤.糖尿病炎性脱髓鞘性周围神经病——附5例报告[J].重庆医科大学学报,2005,30(2):315-317. 被引量:2

二级参考文献38

  • 1余强,李德旺.糖尿病伴自主神经病变患者在室舒张功能的多普勒超声心动图评价[J].重庆医科大学学报,1996,21(3):241-244. 被引量:2
  • 2张贤 曹双林.带状疱疹患者血清可溶性白介素2受体测定[J].临床皮肤科杂志,1999,28(2):94-94.
  • 3曾卫玲.带状疱疹患者外周血T细胞亚群观察[J].云南医药,2000,21(2):97-97.
  • 4曾卫玲,云南医药,2000年,21卷,2期,97页
  • 5张贤,临床皮肤科杂志,1999年,28卷,2期,94页
  • 6Sharma KR,Cross J,Farronay O,et al.Demyelinating neuropathy in diabetes mellitus[J].Arch Neurol,2002;59:758-765.
  • 7Johnson PC,Doll SC,Cromey DW.Pathogenesis of diabetic neuropathy[J].Ann Neurol,1986;19:450-457.
  • 8Younger DS,Rosoklija G,Hays AP,et al.Diabetic peripheral neuropathy:a clinicopathologic and immunohistochemical analysis of sural nerve biopsies[J].Muscle Nerve,1996;19:722-727.
  • 9Comblath DR,Asbury AK,Albers JW,et al.Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force:research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)[J].Neurology,1991;41:617-618.
  • 10Olney RK.Consensus criteria for the diagnosis of partial conduction block[J].Muscle Nerve,1999;22(suppl 8):s225-s229.

共引文献30

同被引文献69

  • 1苗青,丛晓东,王冰,王玉光,张忠德.新型冠状病毒肺炎的中医认识与思考[J].中医杂志,2020,61(4):286-288. 被引量:368
  • 2王海,王燕.中等剂量糖皮质类固醇激素缓解带状疱疹疼痛及肿胀的疗效[J].中国老年学杂志,2014,34(11):2982-2983. 被引量:14
  • 3李玲.套管药栓分层植入治疗腰椎间盘突出症76例[J].中国针灸,2002,22(S1):82-83. 被引量:1
  • 4胥少汀,葛宝丰,徐印坎.实用骨科学[M].4版.北京:人民军医出版社,2012:608.
  • 5Ho TW, Fan X, Rodgers A, et al. Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis ofrizmriptan trials in adults I J]. Cephalalgia, 2009,29 (7): 711 - 718.
  • 6Kuo 33", Aveson VG. Neonatal Fc receptor and IgG - based thera- peutics [ J ]. MAbs, 2011,3 (5) : 422 - 430.
  • 7Spudock NK, Prittie JE. A review of current indications, adverse effects and administration recommendations for intravenous irmnunoglohulin [ J ]. J Vet Emerg Crit Care ( San Antonio), 2011,21(5):471 -483.
  • 8Chen G,Chen S,Chen X. Role of complement and pempectives ~r intervention in transplantation[J].Immunobiology, 2013, 218(5):817 -827.
  • 9Maddur MS, Vani J, Hegde P, et al. Inhibition of differentiation, amplification, and function of human TH17 cells by intravenousimmunoglobulin[J] . J Allergy Clin Immunol, 2011, 127 (3) : 823 - 830.
  • 10Ho TW, Fan X, Rodgers A, et al. Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis ofrizmriptan trials in adults[J]. Cephalalgia, 2009, 29: 711- 718.

引证文献10

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部